np event 2254995 0E193A 1 1
Oct 1, 2026
Clinical Update on the Evolving Role of B-Cell Targeting Therapies to Improve Outcomes in Patients with Generalized Myasthenia Gravis
Virtual Satellite Symposium at the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual Meeting

Date/Time

Thursday, October 1st, 2026 from 11:30am – 12:30pm EDT

Location

To join this virtual session, please utilize the following link:
https://us02web.zoom.us/j/81050789801

Who Should Attend

Neurologists, neuromuscular disease specialists, and other healthcare providers who manage patients with gMG

Accreditation Statement

Joint

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AcademicCME designates this live material for a maximum of 1.0 AMA PRA Category 1 CreditTM.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Financial Support

Supported by an independent educational grant from Amgen.

This activity will be held during the AANEM Annual Meeting. It is not part of the official scientific program of the AANEM.

Faculty

Howard Headshot  e1721236596371
James F. Howard Jr., MD
Professor of Neurology, Medicine & Allied Health
Director, Myasthenia Gravis Clinical Trials and Translational Research Program
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Vissing
John Vissing, MD, DMSci
Professor of Neurology
University of Copenhagen
Director, The Copenhagen Neuromuscular Center at the National Hospital, Rigshospitalet
Copenhagen, Denmark
Gil I. Wolfe, MD, FAAN
Gil I. Wolfe, MD
SUNY Distinguished Professor
Department of Neurology/UBMD Neurology
Jacobs School of Medicine and Biomedical Sciences
University at Buffalo/SUNY
Buffalo, New York
Prof. Maria Isabel Leite
Maria C. Leite, MD, DPhil
Associate Professor and Consultant Neurologist
Faculty, Myasthenia Gravis, Neuromuscular Academy
University of Oxford
Oxford, England

Event Details

CE Inquiries/Special Needs

Provided by

AcademicLogo
1

Discuss the pathophysiology and varied symptom presentation associated with gMG, including the role of autoantibodies and other underlying immune mechanisms

2

Review strategies for MG diagnosis using a comprehensive approach that includes biomarkers/autoantibody measurement

3

Evaluate the current standards of care and clinical trial data for emerging therapies to treat patients with MG, including CD19 B-cell depleting therapeutics

4

Develop strategies to individualize treatments by examining mechanisms of action and patient specifics

Faculty

Howard Headshot  e1721236596371
James F. Howard Jr., MD
Professor of Neurology, Medicine & Allied Health
Director, Myasthenia Gravis Clinical Trials and Translational Research Program
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Vissing
John Vissing, MD, DMSci
Professor of Neurology
University of Copenhagen
Director, The Copenhagen Neuromuscular Center at the National Hospital, Rigshospitalet
Copenhagen, Denmark
Gil I. Wolfe, MD, FAAN
Gil I. Wolfe, MD
SUNY Distinguished Professor
Department of Neurology/UBMD Neurology
Jacobs School of Medicine and Biomedical Sciences
University at Buffalo/SUNY
Buffalo, New York
Prof. Maria Isabel Leite
Maria C. Leite, MD, DPhil
Associate Professor and Consultant Neurologist
Faculty, Myasthenia Gravis, Neuromuscular Academy
University of Oxford
Oxford, England

To join this virtual session, please utilize the following link:
https://us02web.zoom.us/j/81050789801

Event Registration

Related Upcoming Events

CME Symposium at the 2026 Eastern Pulmonary Conference
September 13, 2026
Pulmonology
CME Symposium at the 2026 Eastern Pulmonary Conference
September 13, 2026
Pulmonology